The Effectiveness of a Personalised Digital Health Intervention (Naluri) on Self-Care Behaviours and Quality of Life Outcomes among Cardiac Patients at the Malaysian National Heart Institute: A Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Coronary Heart DiseaseCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12619000104156
- Lead Sponsor
- aluri Hidup Sdn Bhd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
•Consent to participate in research
•Have been discharged from the hospital not more than four weeks after diagnosis
•Smart mobile telephone users
•Literate in either English or Malay.
Exclusion Criteria
•Patients who are currently pregnant
•Have end stage liver and kidney disease
•Have a history of cancer undergoing active treatment
•Currently on weight loss medications
•Currently on active psychotropic medications
•Bedridden
•Patients who are already using similar health intervention app
•Patients with life-threathening co-morbidities
•Patients with severe cognitive impairments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in physical activities as measured using the International Physical Activity Questionnaire (IPAQ) [Baseline and at 16 weeks after randomization];Change in diet as measured using the Adherence to Healthy Lifestyle questionnaire[Baseline and at 16 weeks after randomization]
- Secondary Outcome Measures
Name Time Method Quality of life as measured by HeartQOL[Baseline and 16 weeks after randomization];Mean score of the Hospital Anxiety and Depression Scale (HADS)[Baseline and at 16 weeks after randomization ];Composite secondary outcomes consisting of height, weight, blood pressure, HbA1c and cholesterol levels. These will be measured respectively using stadiometers, weighing scales, electronic sphygmomanometers and serum assay.[Baseline and at 16 weeks after randomization];Perception of illness as measured by Brief Illness Perception Questionnaire (BIPQ) [Baseline and at 16 weeks after randomization]